Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial (Prevena-C)
Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean: a Multicenter Randomized Trial
Sponsor: 3M
Terminated
DSMB recommendation following interim analysis
Listed as NCT03009110, this NA trial focuses on Cesarean Section and Surgical Wound Infection and remains terminated or withdrawn. Sponsored by 3M, it has been updated 15 times since 2017, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jul 2023 — Jul 2024 [monthly]
Terminated NA
-
Sep 2022 — Jul 2023 [monthly]
Terminated NA
▶ Show 10 earlier versions
-
Jan 2021 — Sep 2022 [monthly]
Terminated NA
-
Feb 2020 — Jan 2021 [monthly]
Terminated NA
-
Dec 2019 — Feb 2020 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Nov 2019 — Dec 2019 [monthly]
Recruiting NA
-
Apr 2019 — Nov 2019 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
-
Aug 2017 — Dec 2017 [monthly]
Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting · Phase: PHASE3 → NA
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- 3M
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Indiana University
For direct contact, visit the study record on ClinicalTrials.gov .